2021
DOI: 10.1017/exp.2021.5
|View full text |Cite
|
Sign up to set email alerts
|

The effect of ultrafiltration transmembrane permeation on the flow field in a surrogate system of an artificial kidney

Abstract: Renal Replacement Therapies generally associated to the Artificial Kidney (AK) are membrane-based treatments that assure the separation functions of the failing kidney in extracorporeal blood circulation. Their progress from conventional hemodialysis towards high-flux hemodialysis (HFHD) through the introduction of ultrafiltration membranes characterized by high convective permeation fluxes intensified the need of elucidating the effect of the membrane fluid removal rates on the increase of the potentially blo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 10 publications
(10 reference statements)
0
6
0
Order By: Relevance
“…In terms of permeation performance, the CA/SiO 2 membranes were classified as suitable for high-flux hemodialysis, fully permeated urea, creatinine, uric acid (surrogate markers of low molecular weight water-soluble compounds (LMWMs)), and p -cresyl sulfate (a surrogate marker of PBUTs) while completely rejecting albumin (a vital component of the blood which cannot be removed by hemodialysis membranes) [ 21 ]. Andrade et al [ 22 ] developed another group of MHMs, CA/SiO 2 /SiO 1.5 -(CH 2 ) 3 NH 2 , using two silicon precursors: TEOS (up to 5 mol%) and (3-aminopropyl)-triethoxysilane (APTES) (up to 50 mol%).…”
Section: Introductionmentioning
confidence: 99%
“…In terms of permeation performance, the CA/SiO 2 membranes were classified as suitable for high-flux hemodialysis, fully permeated urea, creatinine, uric acid (surrogate markers of low molecular weight water-soluble compounds (LMWMs)), and p -cresyl sulfate (a surrogate marker of PBUTs) while completely rejecting albumin (a vital component of the blood which cannot be removed by hemodialysis membranes) [ 21 ]. Andrade et al [ 22 ] developed another group of MHMs, CA/SiO 2 /SiO 1.5 -(CH 2 ) 3 NH 2 , using two silicon precursors: TEOS (up to 5 mol%) and (3-aminopropyl)-triethoxysilane (APTES) (up to 50 mol%).…”
Section: Introductionmentioning
confidence: 99%
“…Gonçalves and Faria pioneered an innovative strategy to fabricate monophasic hybrid CA/SiO 2 -based membranes [ 7 , 8 , 9 , 10 , 11 , 12 ] by combining the membranes’ phase inversion technique [ 13 ] with sol–gel methodology [ 14 , 15 ]. In this approach, in situ homo- and hetero-condensation reactions take place during casting solution homogenization (under acid catalysis) between silanols (≡Si–OH−) from the hydrolyzed silica precursors and silanols and hydroxyls (OH−) from the CA polymer, respectively.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, CA membranes exhibit some drawbacks-namely, limited chemical resistance, low mechanical strength, low shelf life, and small pore size [23]. To overcome these limitations, our research group has focused on the development of novel monophasic hybrid CA-based membranes, which combine the high mechanical and thermal stability of the inorganic material with the flexibility, ductility, and processability of CA [24][25][26][27][28]. In a recent study [27], a modified version of the phase inversion technique [13] coupled with the sol-gel method [29,30] was used to synthesize novel monophasic hybrid skinned amine-functionalized CA-SiO 2 -(CH 2 ) 3 NH 2 membranes.…”
Section: Introductionmentioning
confidence: 99%